PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.06
0.06 - 0.24
2.78M / 3.59M (Avg.)
-1.55 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.77%
5Y revenue/share CAGR under 50% of SMR.AX's 189.93%. Michael Burry would suspect a significant competitive gap or product weakness.
2.46%
3Y revenue/share CAGR under 50% of SMR.AX's 228.48%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
359.87%
OCF/share CAGR of 359.87% while SMR.AX is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-33.91%
Negative 5Y OCF/share CAGR while SMR.AX is at 323.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
138.76%
3Y OCF/share CAGR under 50% of SMR.AX's 646.73%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
29.54%
Below 50% of SMR.AX's 3827.45%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
957.27%
5Y net income/share CAGR above 1.5x SMR.AX's 103.71%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
298.41%
3Y net income/share CAGR 75-90% of SMR.AX's 380.05%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
-89.86%
Negative equity/share CAGR over 10 years while SMR.AX stands at 1713.67%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
209.87%
Below 50% of SMR.AX's 508.76%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
1153.54%
3Y equity/share CAGR above 1.5x SMR.AX's 276.74%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6126955.88%
Our short-term dividend growth is positive while SMR.AX cut theirs. John Neff views it as a comparative advantage in shareholder returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.